I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Does the proteasome inhibitor bortezomib sensitize to DNA-d..:
Franziska Briest
;
Eva J. Koziolek
;
Jakob Albrecht
...
http://www.sciencedirect.com/science/article/pii/S147655862030172X. , 2021
Link:
https://doi.org/10.1016/j.neo.2020.11.004
RT Journal T1
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ae7137f1c25a44b7a686f53aa5278365&Exemplar=1&LAN=DE A1 Franziska Briest A1 Eva J. Koziolek A1 Jakob Albrecht A1 Fränze Schmidt A1 Monique R. Bernsen A1 Joost Haeck A1 Anja A. Kühl A1 Dagmar Sedding A1 Teresa Hartung A1 Samantha Exner A1 Martina Welzel A1 Christian Fischer A1 Carsten Grötzinger A1 Winfried Brenner A1 Richard P. Baum A1 Patricia Grabowski PB Elsevier YR 2021 K1 Bortezomib K1 Neuroendocrine tumors K1 Peptide receptor radionuclide therapy (PRRT) K1 DNA repair K1 Combination therapy K1 Proteasome inhibition K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S147655862030172X LK http://dx.doi.org/https://doi.org/10.1016/j.neo.2020.11.004 DO https://doi.org/10.1016/j.neo.2020.11.004 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)